• Blackstone (NYSE:BX) is supplying a large private credit facility for BGH Capital’s purchase of Aspen Pharmacare’s Asia Pacific operations.
• The firm is also arranging a multi billion dollar loan to support Australian startup Firmus Technologies as it expands AI focused data centers.
• These deals highlight Blackstone’s growing role in private credit and digital infrastructure financing.

For investors watching NYSE:BX, these moves come at a time when the shares trade around $129.69 and longer term returns have been mixed. The stock is down 8.9% over the past week, 15.6% over the past month, and 18.3% year to date, while the 3 year and 5 year returns of 51.1% and 116.6% reflect gains over a longer horizon.

Blackstone’s push into private credit for healthcare assets and AI focused data centers could influence how its business mix evolves over time. For investors, these transactions may be useful to watch as signals of where the firm is concentrating capital and which parts of the market it is prioritizing.

Stay updated on the most important news stories for Blackstone by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Blackstone.

For Blackstone, the Aspen private credit facility and the A$5b plus Firmus Technologies data center loan both point to a heavier tilt toward healthcare-related credit and AI-focused digital infrastructure financing, areas that can sit alongside its existing private equity, real estate and credit platforms. These transactions also show Blackstone operating in the same opportunity set as peers like Apollo Global Management and KKR, using large, covenant-lite loans and long-duration infrastructure exposure to potentially deepen fee-paying assets across credit and infrastructure.

How this fits with the Blackstone narrative investors are watching

These deals sit squarely in the themes analysts have been talking about for Blackstone, including growth in private credit, infrastructure and large-scale deployments that can reshape the fee base over time. They also connect to previous commentary that highlighted both the potential for higher fee-related earnings and the execution and integration risks that come with rapid expansion into sectors like digital infrastructure and data centers.

Risks and rewards investors should keep in mind

• Large private credit deals in healthcare and AI-linked data centers add fee opportunities that align with Blackstone’s focus on credit, infrastructure and long-term capital deployment.
• The Aspen financing and Firmus loan reinforce Blackstone’s position alongside managers like Apollo and Goldman Sachs Asset Management in multi billion dollar private credit solutions, which some investors see as an important growth channel.
• The Aspen loan is expected to be covenant-lite with leverage around 6.5x earnings, which adds credit risk that investors may want to weigh against the potential return profile.
• Expanding into capital-intensive AI data centers can expose Blackstone to technology shifts and regulatory attention, including the scrutiny already mentioned around Australia’s private credit market.

What to watch next

From here, it is worth tracking how quickly these loans close, what fee terms Blackstone discloses, and whether management links them to future fundraising in private credit and infrastructure when discussing results. If you want to see how deals like this fit into longer-term views on growth, risk and valuation, have a look at community narratives for Blackstone on Simply Wall St, which pull these moving parts into full storylines other investors are using.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.